Postmarketing Safety Study of Q/LAIV in Subjects 2 Through 49 Years of Age

Safety and Immunogenicity of Q Fever Vaccine

NCT02092142 ·Status: WITHDRAWN ·Phase: PHASE2

NDV-HXP-S Vaccine Clinical Trial (COVIVAC)

NCT05940194 ·Status: COMPLETED ·Phase: PHASE2

Crossover Vaccination of Women Previously Randomized Into Protocol 04-C-N191

NCT01086709 ·Status: COMPLETED

A Study to Evaluate Long-term Impact of VARIVAX Among Children and Adolescents (V210-036)(COMPLETED)

NCT01077804 ·Status: COMPLETED

A TRIAL TO EVALUATE THE SAFETY, TOLERABILITY, AND IMMUNOGENICITY OF A BOOSTER DOSE OF A GROUP B STREPTOCOCCUS 6 VALENT POLYSACCHARIDE CONJUGATE VACCINE (GBS6) IN HEALTHY ADULTS

NCT04258995 ·Status: COMPLETED ·Phase: PHASE2

A Study in Healthy Adults Having Received a Single Vaccine Administration to Support the Development of Immunological Assays

NCT01099488 ·Status: COMPLETED ·Phase: NA

Primary Study to Demonstrate Non-inferiority and Immunogenicity of GSK Biologicals' Meningococcal Vaccine 134612

NCT00465816 ·Status: COMPLETED ·Phase: PHASE3

Safety and Immunogenicity of CVI-VZV-001 for Prevention of Herpes Zoster in Healthy Adults Age 50 Years and Above

NCT06137755 ·Status: RECRUITING ·Phase: PHASE1

Safety and Immunogenicity Study of AdCLD-CoV19: A COVID-19 Preventive Vaccine in Healthy Volunteers

NCT04666012 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

Safety and Immunogenicity of AdCLD-CoV19-1 OMI as a Booster: A SARS-CoV-2 (COVID-19) Preventive Vaccine

NCT05576623 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

Safety of an Inactivated SARS-CoV-2 Vaccine for Prevention of COVID-19 in Adults

NCT04911790 ·Status: COMPLETED ·Phase: PHASE4

Safety and Immunogenicity Study of ACYW135 Meningococcal Polysaccharide Vaccine Aged 2-50 Years Old

NCT02869672 ·Status: UNKNOWN ·Phase: PHASE3

Safety and Immunogenicity of a Klebsiella Pneumoniae Tetravalent Bioconjugate Vaccine (Kleb4V)

NCT04959344 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

A Comparability Study of the Phase 3 Lot and a Single Commercial Lot of NicVAX in Healthy Adult Smokers

NCT01375933 ·Status: COMPLETED ·Phase: PHASE3

Vaccine To Prevent Cervical Intraepithelial Neoplasia or Cervical Cancer in Younger Healthy Participants

NCT00128661 ·Status: COMPLETED ·Phase: PHASE3

Trial of the Immunogenicity, Safety, and Tolerability of rF1V Vaccine With CpG 1018® Adjuvant Compared With rF1V Vaccine in Adults 18 to 55 Years of Age

NCT05506969 ·Status: COMPLETED ·Phase: PHASE2

Trial to Compare the Safety,Tolerability and Efficacy of Influenza Virus Vaccine, (CAIV-T) With Influenza Virus Vaccine, Trivalent, Inactivated (TIV) in Children

NCT00192205 ·Status: COMPLETED ·Phase: PHASE3

Safety of an Inactivated SARS-CoV-2 Vaccine for Prevention of COVID-19 in Children and Adolescents

NCT04992208 ·Status: COMPLETED ·Phase: PHASE4

Adolescents Seeking COVID Vaccination (Teen COVID Vax)

NCT05537103 ·Status: COMPLETED

Recombinant COVID-19 Vaccine (CHO Cell, NVSI-06-09) Phase III Clinical Trial

NCT05599516 ·Status: UNKNOWN ·Phase: PHASE3

Immune Memory After Papillomavirus Vaccination

NCT01505049 ·Status: COMPLETED

A Post-marketing Observational Database Study Monitoring the Safety of CecolinⓇ

NCT06824896 ·Status: COMPLETED

A Phase III Study of a 2-dose Regimen of a Multivalent Human Papillomavirus (HPV) Vaccine (V503), Administered to 9 to 14 Year-olds and Compared to Young Women, 16 to 26 Years Old (V503-010)

NCT01984697 ·Status: COMPLETED ·Phase: PHASE3

An Open Comprative Study of the Prophylactic Efficacy and a Non-comparative Study of the Immunogenicity and Safety of the Inactivated Whole-virion Concentrated Purified Coronavirus Vaccine (CoviVac)

NCT05407142 ·Status: UNKNOWN ·Phase: PHASE3

Phase I Trial Evaluating Safety and Tolerability of CAIV-T in Healthy Japanese Male Adults

NCT00224783 ·Status: COMPLETED ·Phase: PHASE1